lamivudine has been researched along with Spondylarthropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Martino, V; Herbein, G; Prati, C; Toussirot, E; Wendling, D | 1 |
| Apostolopoulou, A; Archimandritis, AI; Hadziyannis, E; Koskinas, J; Manesis, EK; Manolakopoulos, S; Papatheodoridis, GV; Vassilopoulos, D | 1 |
| Albert, C; Breuil, V; Brocq, O; Euller-Ziegler, L; Roux, CH | 1 |
1 trial(s) available for lamivudine and Spondylarthropathies
| Article | Year |
|---|---|
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
Topics: Adult; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Female; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Spondylarthropathies; Tumor Necrosis Factor-alpha; Virus Activation | 2010 |
2 other study(ies) available for lamivudine and Spondylarthropathies
| Article | Year |
|---|---|
Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy.
Topics: Adenine; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Antiviral Agents; Drug Therapy, Combination; Etanercept; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Immunoglobulin G; Infliximab; Lamivudine; Male; Methotrexate; Organophosphonates; Receptors, Tumor Necrosis Factor; Spondylarthropathies; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load; Virus Activation | 2009 |
Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Chronic; Humans; Immunoglobulin G; Infliximab; Lamivudine; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Retrospective Studies; Spondylarthropathies; Transaminases; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load | 2006 |